Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer. (Record no. 20555330)

MARC details
000 -LEADER
fixed length control field 01338 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516022442.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201108s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0028-2685
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.4149/neo_2011_02_172
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Vrdoljak, E
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20110804
245 00 - TITLE STATEMENT
Title Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Neoplasma
Date of publication, distribution, etc. 2011
300 ## - PHYSICAL DESCRIPTION
Extent 172-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Capecitabine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Deoxycytidine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fluorouracil
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mitomycin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Metastasis
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Boban, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Omrcen, T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hrepic, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fridl-Vidas, V
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Boskovic, L
773 0# - HOST ITEM ENTRY
Title Neoplasma
Related parts vol. 58
-- no. 2
-- p. 172-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.4149/neo_2011_02_172">https://doi.org/10.4149/neo_2011_02_172</a>
Public note Available from publisher's website

No items available.